Modulus Overview
- Founded
- 2017
- Status
- Private
- Latest Deal Type
- Series C
- Latest Deal Amount
- $20.4M
- Investors
- 15
Modulus General Information
Description
Operator of a pre-clinical stage drug discovery company designed to accelerate the discovery of new medicines. The company's platforms are prepared with cutting-edge computational drug discovery expertise and biology insights and focus on rapid design and generation of small molecule clinical candidates for a range of high-value disease targets, enabling drug discovery scientists to focus on the efficient delivery of breakthrough medicines for patients and their families with unmet medical needs.
Contact Information
Website
www.modulusdiscovery.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 1 Broadway
- 14th Floor
- Cambridge, MA 02142
- United States
Modulus Timeline
Modulus Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC (Series C) | 01-Mar-2022 | $20.4M | 000.00 | Completed | Pre-Clinical Trials | |
| 3. Early Stage VC (Series B) | 13-May-2020 | 000.00 | 000.00 | Completed | Pre-Clinical Trials | |
| 2. Early Stage VC (Series A) | 09-Aug-2018 | $7.17M | $10.8M | Completed | Pre-Clinical Trials | |
| 1. Seed Round | 23-Aug-2017 | $3.63M | $3.63M | Completed | Startup |
Modulus Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a pre-clinical stage drug discovery company designed to accelerate the discovery of new medicines. The compa
Drug Discovery
Cambridge, MA
000.00
00000000000
000.00
00000 00
minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Dui
0000000000000
Pittsburgh, PA
0
As of 0000
00.000
0000000000 0
00.000
0000000
iam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute ir
0000 000000000
Maastricht, Netherlands
00
As of 0000
000.00
0000000000
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialModulus Competitors (33)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sharp Edge Labs | Venture Capital-Backed | Pittsburgh, PA | 0 | 00.000 | 0000000000 0 | 00.000 |
| 0000000 0000000000 | Venture Capital-Backed | Maastricht, Netherlands | 00 | 000.00 | 0000000000 | 000.00 |
| 00000000 | Formerly VC-backed | Exton, PA | 00 | 00000 | 000000000 | 00000 |
| 0000000 0000000000 | Formerly VC-backed | Brisbane, CA | 000 | 0000 | 00000000 | 0000 |
| 0000000000 | Formerly VC-backed | Menlo Park, CA | 000 | 00000 | 00000000 | 00000 |
Modulus Executive Team (4)
Modulus Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Kazuki Ohno | Modulus | Co-Founder, Chief Operating Officer, Representative Director, President & Board Member | 000 0000 |
| Suguru Kimura Ph.D | Modulus | Co-Founder, Chief Executive Officer, Representative Director & Board Member | 000 0000 |
| Tomohiro Anzai Ph.D | Fast Track Initiative | Board Member | 000 0000 |
Modulus Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Green Co-Invest Investment | Other | Minority | 000 0000 | 000000 0 | |
| Heights Capital Management | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Dai-Ichi Life Insurance | Limited Partner | Minority | 000 0000 | 000000 0 | |
| Essential Pharma | Corporation | Minority | 000 0000 | 000000 0 | |
| Jafco | Venture Capital | Minority | 000 0000 | 000000 0 |